Brought to you by 
StemCells nets $33.7mm with private placement
04 May 2006
Executive Summary
StemCells (therapeutics for CNS, liver, and pancreatic diseases) netted about $33.7mm through the private placement of 11.75mm common shares priced at $3.05 each (a 16% discount to the market average) to institutional investors. UBS Securities acted as the placement agent.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Financing
- Private Investment in Public Equity
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
StemCells nets $33.7mm with private placement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice